Does EBV RNA modulate ADA mRNA translation?
TO THE EDITOR Epstein-Barr virus (EBV) is a human herpesvirus associated with various haematological pathologies including lymphoma. The usual outcome of EBV infection is latent infection of B lymphocytes and occasional transformation of their cell growth to ceaseless proliferation. Lytic infection results from spontaneous activation of viral replication. EBER-1 and 2 are small, nontranslated transcripts which are transcribed by RNA polymerase III from the EBV genome in both lytic and latently infected cells. EBERs are highly abundant in infected cells, and there is significant conservation of their sequences among different EBV strains. However, EBERs are not required for normal virus gene expression. It has been suggested that EBERs play a role in protecting EBV from antiviral effects during the establishment of latent infection in vivo. More specifically, blocking of (dsRNA)-activated protein kinase (PKR) activity by EBER-1 was proposed as the mechanism used by EBV to overcome translation inhibition. 1 We would like to propose a role for EBER-2, in repression of the immune response against the virus.
EBV-infected cells were shown to secrete a low molecular weight, trypsin-and heat-resistant suppressor factor(s) responsible for neuraminidase-sensitive immune suppression. 2 The physical characteristics of the secreted factor, together with the neuraminidase sensitivity of A2-adenosine receptor, 3 suggest that the suppression activity might be mediated by adenosine, which has already been well established as an inhibitor of monocyte, cytotoxic T lymphocyte and neutrophil function. 4 In contrast to other cells, B lymphocytes can, under stress conditions, release significant amounts of adenosine. 5 We would like to propose an EBER-2-dependent mechanism for adenosine accumulation in EBV-infected B cells. The association of EBERs with cellular La-autoantigen which have dsRNA unwinding activity, 1 may lead to partial melting of the EBER secondary structure, rendering it available for hybridization with a target cellular mRNA. A search of the GenBank has revealed three regions of complementarity between EBER-2 and human adenosine deaminase (ADA) mRNA. transcripts per infected cell) may serve as an anti-sense RNA or a trans-ribozyme against the cellular ADA mRNA, thus leading to inhibition of ADA translation. In fact, in the EBV producer cell lines B95-8 and P3HR-1, comparatively low levels of ADA were detected. 6 Obviously, decreased ADA activity in EBV-infected B lymphocytes leads to significant accumulation of its substrate, adenosine. High levels of secreted adenosine can lead to down-regulation of the immune response against EBV-infected cells and as a consequence, may contribute to the establishment of latent or lytic infection in vivo. 
